AI Article Synopsis

  • IL-17 is a proinflammatory cytokine that enhances the expression of various cytokines and chemokines by promoting gene transcription and stabilizing mRNAs.
  • The study reveals that IL-17 increases the half-life of Zc3h12a mRNA through an interaction between the adaptor protein CIKS and the DEAD box protein DDX3X, requiring the helicase domain of DDX3X.
  • Knockdown of DDX3X reduces the stability of Zc3h12a mRNA without impacting other mRNAs, and additional proteins like IKKε and TNFR-associated factors are also necessary for this mRNA stabilization process triggered by IL-17.

Article Abstract

IL-17 is a proinflammatory cytokine that promotes the expression of different cytokines and chemokines via the induction of gene transcription and the posttranscriptional stabilization of mRNAs. In this study, we show that IL-17 increases the half-life of the Zc3h12a mRNA via interaction of the adaptor protein CIKS with the DEAD box protein DDX3X. IL-17 stimulation promotes the formation of a complex between CIKS and DDX3X, and this interaction requires the helicase domain of DDX3X but not its ATPase activity. DDX3X knockdown decreases the IL-17-induced stability of Zc3h12a without affecting the stability of other mRNAs. IKKε, TNFR-associated factor 2, and TNFR-associated factor 5 were also required to mediate the IL-17-induced Zc3h12a stabilization. DDX3X directly binds the Zc3h12a mRNA after IL-17 stimulation. Collectively, our findings define a novel, IL-17-dependent mechanism regulating the stabilization of a selected mRNA.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369453PMC
http://dx.doi.org/10.4049/jimmunol.1401589DOI Listing

Publication Analysis

Top Keywords

zc3h12a mrna
12
stability zc3h12a
8
il-17 stimulation
8
tnfr-associated factor
8
zc3h12a
5
il-17
5
ddx3x
5
ciks/ddx3x interaction
4
interaction controls
4
controls stability
4

Similar Publications

Regnase-1 regulates inflammation in T cells of ankylosing spondylitis through the TRAF6.

Immunol Res

December 2024

Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China.

The study aimed to investigate the regulatory role of Regnase-1 in ankylosing spondylitis (AS) inflammation. We collected 10 ml peripheral venous blood and epidemiological data from 45 AS patients and 45 healthy controls and performed enzyme-linked immunosorbent assay (ELISA) experiments to measure the levels of inflammatory cytokines. Then CD3 + T lymphocytes were isolated by magnetic bead sorting method, and the transcriptional levels of Regnase-1 and TNF receptor-associated factor 6 (TRAF6) were detected by real-time quantitative PCR (qRT-PCR).

View Article and Find Full Text PDF

Background And Aims: This study aimed to develop a prognostic model based on DNA methylation-driven genes for patients with early-stage gastric cancer and to examine immune infiltration and function across varying risk levels.

Methods: We analyzed data from stage I/II gastric cancer patients in The Cancer Genome Atlas which included clinical details, mRNA expression profiles, and level 3 DNA methylation array data. Using the empirical Bayes method of the limma package, we identified differentially expressed genes (DEGs), and the MethylMix package facilitated the identification of DNA methylation-driven genes (DMGs).

View Article and Find Full Text PDF

MCPIP1 modulates the miRNA‒mRNA landscape in keratinocyte carcinomas.

J Exp Clin Cancer Res

October 2024

Faculty of Biochemistry, Biophysics and Biotechnology, Department of General Biochemistry, Jagiellonian University, Gronostajowa 7, Krakow, 30-387, Poland.

Article Synopsis
  • MCPIP1 is a protein that helps control inflammation and may prevent tumors; mice lacking this protein are more prone to developing skin tumors from certain chemical exposures.
  • The study used advanced sequencing techniques to explore how MCPIP1 regulates specific microRNAs and their effect on gene expression in skin tumors induced by chemicals.
  • Findings revealed significant changes in gene expression with 2400 different protein-coding genes and 33 microRNAs affected, highlighting the direct impact of MCPIP1 on microRNA levels and its role in promoting skin cancer cell growth.
View Article and Find Full Text PDF

MCPIP1 Elicits a Therapeutic Effect on Cervical Cancer by Facilitating XIAP mRNA Decay via Its Endoribonuclease Activity.

Int J Mol Sci

September 2024

Hunan Provincial Key Laboratory of Medical Virology, Institute of Pathogen Biology and Immunology of College of Biology, Hunan University, Changsha 410082, China.

Article Synopsis
  • * Researchers have found that MCPIP1, a protein with specific domains, helps inhibit cervical cancer cell growth and promotes programmed cell death (apoptosis) by targeting a known inhibitor of apoptosis called XIAP.
  • * Targeted delivery of MCPIP1 in mice shows promising results by slowing down tumor growth, suggesting potential new strategies for treating cervical cancer in clinical settings.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!